Login
← Go Back
Morepen Laboratories
MOREPENLAB · Pharma > Pharmaceuticals & Drugs · Chairman: Sushil Suri · MD: Sushil Suri · Listing date: May 10, 1995 · Employees: 1510 · New Delhi · http://www.morepen.com
Stock Price vs Company Growth
1d
4.0%
1w
8.3%
1m
5.3%
3m
7.4%
6m
48.7%
1y
66.0%
5y
38.1%
10y
25.4%
all
10.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 79.9 4.0%
72.7
94.5
Company Overview
Sales
1,761 Cr
Growth: 13.3%
Profit after Tax
131 Cr
Growth: 11.5%
Small Cap
4,379 Cr
P/E: 31.6x
Industry P/E: 37.3x
Fundamentals
Sales (Cr) ₹ 1,761
Growth 13.3%
EBITDA 11.1%
P/S 2.5x
Dividend 0.0%
P/E 31.6x
Book Value ₹ 16.9
PEG Ratio 2.4x
ROE 15.1%
P/B 4.7x
Shareholding Pattern
Institutions
Pinfold Overseas Limited
8.57 %
Ferry Holdings Limited
4.45 %
Damodar Prasad Agarwal
1.63 %
Morepen Laboratories Limited
1.25 %
Promoters
Scope Credits & Financial Services Pvt. Ltd.
2.68 %
Concept Credits & Consultants Pvt. Ltd.
2.63 %
Brook Investments & Financial Services Pvt. Ltd.
2.59 %
Solitary Investments & Financial Services Pvt. Ltd
2.58 %
Solace Investments & Financial Services Pvt. Ltd.
2.57 %
Others
Increase    Decrease    No change
Company Profile Detailed
Established in the year 1984, Morepen Laboratories is a fast growing Pharmaceutical company listed in all major stock exchanges in India including Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) since 1993 with an investors base of 62,400 shareholders.Morepen has steadily grown from a single product company to a multi activity company with a global vision and satisfied customers in over 50 countries.
Belongs to (4 Indices)
Investors (84)
kb.suri....
state.ba...
solitary...
Followers (12)
sunil9
sudheer....
putta